Equity MRK
Tuesday, September 18, 2018   
Adani Ports  377.55    (-1.02%)
 
Asian Paints  1291.15    (-1.08%)
 
Axis Bank  608.45    (-2.81%)
 
Bajaj Auto  2775.90    (-2.84%)
 
Bharti Airtel  373.55    (-2.31%)
 
Coal India  273.45    (-0.49%)
 
H D F C  1856.15    (-1.20%)
 
HDFC Bank  1993.35    (0.05%)
 
Hero Motocorp  3111.65    (-0.66%)
 
Hind. Unilever  1666.15    (3.87%)
 
ICICI Bank  318.70    (-2.07%)
 
IndusInd Bank  1861.45    (-0.84%)
 
Infosys  719.15    (-1.02%)
 
ITC  302.60    (0.23%)
 
Kotak Mah. Ban...  1216.25    (-1.11%)
 
Larsen & Toubr...  1328.70    (-1.16%)
 
M & M  947.30    (0.01%)
 
Maruti Suzuki  8400.10    (-1.56%)
 
NTPC  169.70    (-1.68%)
 
O N G C  173.35    (0.93%)
 
Power Grid Cor...  198.65    (-1.41%)
 
Reliance Inds.  1217.20    (-0.74%)
 
St Bk of India  274.00    (-4.06%)
 
Sun Pharma.Ind...  642.30    (-0.60%)
 
Tata Motors  251.45    (-3.36%)
 
Tata Motors-DV...  137.55    (-2.45%)
 
Tata Steel  612.45    (-0.52%)
 
TCS  2070.00    (-0.08%)
 
Vedanta  230.10    (-1.94%)
 
Wipro  332.50    (1.02%)
 
Yes Bank  323.15    (1.43%)
 
Market Menu
plusminDaily Market Tracker
plusminNews
Corporate Information
Corporate Actions
Other Markets
Close
You are here : Equity | News | Corporate News
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA
(13:08, 12 Jul 2018)
Cadila Healthcare announced that the manufacturing facility of Zydus Hopsira Oncology, a 50:50 joint venture company between Zydus Cadila and Hospira Inc., USA (now part of Pfizer Group) at Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA which concluded that the inspection is closed and states that theinspection classification of this facility is 'Voluntary Action Indicated' (VAI). The manufacturing plant had completed the USFDA audit from 5 to 12 April, 2018.

Powered by Capital Market - Live News